Skip to content

Clinical trials

Recruiting Carcinoma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Status: Recruiting Country / region: Australia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20211
20221
20232
20241
20252
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer4
Merck Sharp & Dohme LLC2
AstraZeneca1
DualityBio Inc.1
Iovance Biotherapeutics, Inc.1
Myeloid Therapeutics1
Taiho Oncology, Inc.1
Trans Tasman Radiation Oncology Group1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma13
Carcinoma, Non-Small-Cell Lung9
Lung Neoplasms7
Lung Diseases4
Neoplasm Metastasis3
Bronchial Neoplasms2
Carcinoma, Renal Cell2
Gastrointestinal Neoplasms2
Neoplasms2
Adenocarcinoma1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.